Log In
Print
BCIQ
Print
Print this Print this
 

TA-H8

  Manage Alerts
Collapse Summary General Information
Company TeraDiscoveries Inc.
DescriptionHistone deacetylase 8 (HDAC8) inhibitor
Molecular Target Histone deacetylase 8 (HDAC8)
Mechanism of ActionHistone deacetylase 8 (HDAC8) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationT cell lymphoma
Indication DetailsTreat T cell lymphoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today